These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13438432)

  • 1. [Variations in coagulation determined in vitro by Marbet and Winterstein heparin test as a function of Quick values and different thrombocyte concentrations].
    PETTAVEL J; WUILLERET B
    Helv Chir Acta; 1957 Mar; 24(1):39-46. PubMed ID: 13438432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of the thrombocytes in thrombogenesis, medicamentous influencing of thrombocyte function].
    Montigel C
    Zentralbl Phlebol; 1968 Feb; 7(1):105-9. PubMed ID: 5682809
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variations in blood coagulation time in presence of heparin as a function of concentration of blood platelets].
    CAZAL P; IZARN P
    Acta Haematol; 1953 Jul; 10(1):37-45. PubMed ID: 13079578
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.
    Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration.
    Tucci MA; Ganter MT; Hamiel CR; Klaghofer R; Zollinger A; Hofer CK
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1314-22. PubMed ID: 16733164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin release is insufficient in syringes with platelets as heparin source.
    Gruber M; Spaeth R; Bechmann V
    Clin Chim Acta; 2008 Sep; 395(1-2):187. PubMed ID: 18515082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of mutual relationship between thrombocyte count, bleeding time and susceptibility to hemorrhage in essential thrombopenia].
    KOCAR J
    Cas Lek Cesk; 1952 Aug; 91(31):905-8. PubMed ID: 14390312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phase-optical thrombocyte studies during coagulation in vitro].
    ACHENBACH W; RYSSEL U
    Med Welt; 1962 Apr; 17():947-53 passim. PubMed ID: 13859138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Respective values of thromboelastography by Harterl and of the heparin tolerance test in vitro in thrombophilic states].
    DELLA SANTA R; DURAFFOURD P
    Schweiz Med Wochenschr; 1954 Sep; 84(39):1128-30. PubMed ID: 13216166
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique.
    Sperling C; Houska M; Brynda E; Streller U; Werner C
    J Biomed Mater Res A; 2006 Mar; 76(4):681-9. PubMed ID: 16302224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocyte factors].
    LUESCHER EF
    Ergeb Physiol; 1959; 50():1-74. PubMed ID: 14418756
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on platelet function. III. Study of changes in platelets and coagulation factor during blood storage].
    NISHIKAWA T
    Naika Hokan; 1961; 8():451-7. PubMed ID: 13729221
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on thrombocyte isolation for physiological and immunobematological studies on blood coagulation].
    FISCHER K; LANDBECK G
    Klin Wochenschr; 1959 May; 37(10):562-3. PubMed ID: 13673521
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation.
    Johnell M; Larsson R; Siegbahn A
    Biomaterials; 2005 May; 26(14):1731-9. PubMed ID: 15576147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the effect of thrombocyte hyalomere on the retraction process].
    FONIO A
    Acta Haematol; 1952 Dec; 8(6):363-7. PubMed ID: 13039915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.